
Korean Biotech Firms Breathe Sigh of Relief as U.S. Announces 1-year Tariff Delay
The Korean pharmaceutical and biotech industry is breathing a sigh of relief after U.S. President Donald Trump announced that he would delay the imposition of tariffs on imported drugs by more than a year. However, as he stated that high tariffs of up to …